• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Infect Chemother . Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities

tetano

Editor, Senior Moderator
J Infect Chemother


. 2022 Jun 13;S1341-321X(22)00177-5.
doi: 10.1016/j.jiac.2022.06.002. Online ahead of print.
Risk factors associated with hospitalization in patients with asymptomatic or mild COVID-19 in public accommodation facilities in Tokyo


Yohei Sakamoto[SUP] 1 [/SUP], Kenichi Satoh[SUP] 2 [/SUP], Takuma Tanaka[SUP] 2 [/SUP], Takayuki Yamaguchi[SUP] 2 [/SUP], Tomomi Miyamoto[SUP] 3 [/SUP], Kenji Sawaki[SUP] 3 [/SUP], Makiko Miyajima[SUP] 3 [/SUP], Kazuhiko Nakaharai[SUP] 3 [/SUP], Tokio Hoshina[SUP] 3 [/SUP], Tetsuya Horino[SUP] 3 [/SUP], Yasushi Nakazawa[SUP] 3 [/SUP], Tatsuyoshi Ikenoue[SUP] 2 [/SUP], Masaki Yoshida[SUP] 3 [/SUP]



Affiliations

Abstract

Introduction: In Japan, patients with coronavirus disease 2019 (COVID-19) who do not require medical intervention are provided care in recovery accommodation facilities (RAFs). However, some patients may require hospitalization if their symptoms become more severe during their stay. We conducted an observational study using epidemiological data of patients with COVID-19 admitted to RAFs in Tokyo.
Methods: This was an observational cohort study using data from COVID-19 patients admitted to one of the RAFs in Tokyo from December 2020 to November 2021. Admissions to the facilities were limited to patients with asymptomatic or mild COVID-19 with no underlying disease or at least stable underlying disease at the time of admission. Patients were hospitalized when they required oxygen administration or when they had, or persistent fever, or severe respiratory symptoms. We evaluated the association between hospitalization and the risk factors for hospitalization using a Cox regression model.
Results: The number of patients with COVID-19 admitted to the RAF was 6176. The number of hospitalized patients was 393 (6.4%), and the median length of stay was 5.50 days (IQR: 4.50, 6.50). In the Cox regression analysis, the hazard ratio increased with age and was significantly higher among patients aged >60 years (HR = 10.23, 95% CI: 6.72-15.57) than those in other age groups. This trend is similar to that observed in the sensitivity analysis.
Conclusion: Patients with diabetes, the elderly, obesity, and medications for gout and psychiatric diseases may be at a high risk of hospitalization. In particular, an age over 60 years was strongly associated with hospitalization.

Keywords: COVID-19; Cox regression model; Psychiatric medication; Recovery accommodation facility.
 
Back
Top Bottom